Longeveron/$LGVN
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Longeveron
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
Ticker
$LGVN
Sector
Primary listing
Employees
25
Headquarters
Website
Longeveron Metrics
BasicAdvanced
$16M
-
-$1.90
-
-
Price and volume
Market cap
$16M
52-week high
$2.24
52-week low
$0.63
Average daily volume
471K
Financial strength
Current ratio
2.093
Quick ratio
1.882
Long term debt to equity
3.371
Total debt to equity
9.864
Profitability
EBITDA (TTM)
-20.979
Gross margin (TTM)
74.88%
Net profit margin (TTM)
-1,485.11%
Operating margin (TTM)
-1,542.73%
Revenue per employee (TTM)
$60,000
Management effectiveness
Return on assets (TTM)
-60.95%
Return on equity (TTM)
-119.92%
Valuation
Price to revenue (TTM)
8.48
Price to book
1.63
Price to tangible book (TTM)
2.12
Price to free cash flow (TTM)
-0.701
Free cash flow yield (TTM)
-142.60%
Free cash flow per share (TTM)
-1.098
Growth
Revenue change (TTM)
-22.41%
Earnings per share change (TTM)
-55.25%
3-year revenue growth (CAGR)
3.13%
3-year earnings per share growth (CAGR)
-40.29%
What the Analysts think about Longeveron
Majority rating from 2 analysts.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Longeveron stock?
Longeveron (LGVN) has a market cap of $16M as of November 07, 2025.
What is the P/E ratio for Longeveron stock?
The price to earnings (P/E) ratio for Longeveron (LGVN) stock is 0 as of November 07, 2025.
Does Longeveron stock pay dividends?
No, Longeveron (LGVN) stock does not pay dividends to its shareholders as of November 07, 2025.
When is the next Longeveron dividend payment date?
Longeveron (LGVN) stock does not pay dividends to its shareholders.
What is the beta indicator for Longeveron?
Longeveron (LGVN) does not currently have a Beta indicator.